Research output per year
Research output per year
Personal profile
Research interests
Bone marrow transplantation, leukemia, myelodysplastic syndrome
Clinical interests
Medical oncology, hematology
Fingerprint
Dive into the research topics where Meagan Jacoby is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Efficacy and safety of venetoclax plus azacitidine for patients with treatment-naive high-risk myelodysplastic syndromes
Garcia, J. S., Platzbecker, U., Odenike, O., Fleming, S., Fong, C. Y., Borate, U., Jacoby, M. A., Nowak, D., Baer, M. R., Peterlin, P., Chyla, B., Wang, H., Ku, G., Hoffman, D., Potluri, J. & Garcia-Manero, G., Mar 13 2025, In: Blood. 145, 11, p. 1126-1135 10 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Itacitinib for prevention of graft-versus-host disease and cytokine release syndrome in haploidentical transplantation
Abboud, R., Schroeder, M. A., Rettig, M. P., Jayasinghe, R. G., Gao, F., Eisele, J., Gehrs, L., Ritchey, J., Choi, J., Abboud, C. N., Pusic, I., Jacoby, M., Westervelt, P., Christopher, M., Cashen, A., Ghobadi, A., Stockerl-Goldstein, K., Uy, G. L. & DiPersio, J. F., Mar 27 2025, In: Blood. 145, 13, p. 1382-1394 13 p.Research output: Contribution to journal › Article › peer-review
-
Monitoring clonal burden as an alternative to blast count for myelodysplastic neoplasm treatment response: EARLY PHASE STUDIES
Jacoby, M. A., Duncavage, E. D., Khanna, A., Chang, G. S., Nonavinkere Srivatsan, S., Miller, C. A., Gao, F., Robinson, J., Shao, J., Fulton, R. S., Fronick, C. C., O’Laughlin, M., Heath, S. E., Brendel, K., Chavez, M., DiPersio, J. F., Abboud, C. N., Stockerl-Goldstein, K., Westervelt, P. & Cashen, A. & 7 others, , Jan 2025, In: Leukemia. 39, 1, p. 166-177 12 p.Research output: Contribution to journal › Article › peer-review
-
Clinical whole-genome sequencing and FISH identify two different fusion partners for NUP98 in a patient with acute myeloid leukemia: A case report
Mojarad, B. A., Crees, Z. D., Schroeder, M. C., Xiang, Z., Vader, J., Sina, J., Jacoby, M., Frater, J. L., Duncavage, E. J., Spencer, D. H., Lavine, K., Neidich, J. A. & Amarillo, I., Jan 2024, In: Cancer Genetics. 280-281, p. 1-5 5 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
A randomized phase II/III study of ‘novel therapeutics’ versus azacitidine in newly diagnosed patients with acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML), age 60 or older: a report of the comparison of azacitidine and nivolumab to azacitidine: SWOG S1612
Assouline, S., Michaelis, L. C., Othus, M., Hay, A. E., Walter, R. B., Jacoby, M. A., Schroeder, M. A., Uy, G. L., Law, L. Y., Cheema, F., Sweet, K. L., Asch, A. S., Liu, J., Moseley, A. B., Maher, T., Kingsbury, L. L., Fang, M., Radich, J., Little, R. F. & Erba, H. P., 2023, In: Leukemia and Lymphoma. 64, 2, p. 473-477 5 p.Research output: Contribution to journal › Letter › peer-review
Open Access6 Scopus citations